Growing caseloads of patients with tuberculosis and HIV infection, and larger cohorts of patients needing re treatment, including for MDR tuberculosis, has led to increasing complexity of tuberculosis monitoring and evaluation.
Local capacity to use and benefit from routine data systems remains weak; investment in prevalence surveys and technical support is needed to improve measurement of disease burden and the effect of interventions.